Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bahl

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancerA Bahl, R Singh, J Wadhwa, et al.
Endocrine-Related Cancer|December 10, 2015
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptorL Zeng, H A Zielinska, A Arshad, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 5, 2020
Spine and Non-spine Bone Metastases - Current Controversies and Future DirectionA Challapalli, S Aziz, V Khoo, et al.
British Journal of Cancer|April 14, 2011
Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelC C Uzoh, J M P Holly, K M Biernacka, et al.
Endocrine-Related Cancer|August 21, 2013
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2K M Biernacka, C C Uzoh, L Zeng, et al.
Journal of Bone Oncology|February 25, 2016
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countriesH Hoefeler, I Duran, G Hechmati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid useD Lorente, J Mateo, A J Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2013
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trialA Bahl, S Oudard, B Tombal, et al.
Journal of Medical Economics|February 28, 2013
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational studyG Hechmati, S Cure, A Gouépo, et al.
European Journal of Cancer Care|February 12, 2016
Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational studyI Duran, M G Fink, A Bahl, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
South Asian Journal of Cancer|May 4, 2018
Practical consensus recommendations regarding the management of HER2 neu positive early breast cancerA Bahl, R Singh, J Wadhwa, et al.
Endocrine-Related Cancer|December 10, 2015
Hyperglycaemia-induced chemoresistance in breast cancer cells: role of the estrogen receptorL Zeng, H A Zielinska, A Arshad, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 5, 2020
Spine and Non-spine Bone Metastases - Current Controversies and Future DirectionA Challapalli, S Aziz, V Khoo, et al.
British Journal of Cancer|April 14, 2011
Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelC C Uzoh, J M P Holly, K M Biernacka, et al.
Endocrine-Related Cancer|August 21, 2013
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2K M Biernacka, C C Uzoh, L Zeng, et al.
Journal of Bone Oncology|February 25, 2016
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countriesH Hoefeler, I Duran, G Hechmati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid useD Lorente, J Mateo, A J Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2013
Impact of cabazitaxel on 2-year survival and palliation of tumour-related pain in men with metastatic castration-resistant prostate cancer treated in the TROPIC trialA Bahl, S Oudard, B Tombal, et al.
Journal of Medical Economics|February 28, 2013
Cost of skeletal-related events in European patients with solid tumours and bone metastases: data from a prospective multinational observational studyG Hechmati, S Cure, A Gouépo, et al.
European Journal of Cancer Care|February 12, 2016
Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational studyI Duran, M G Fink, A Bahl, et al.
Pageof 7